Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)

Elvira O. G. van Vliet, Ewoud Schuit, Karst Y. Heida, Brent C. Opmeer, Marjolein Kok, Wilfried Gyselaers, Martina M. Porath, Mallory Woiski, Caroline J. Bax, Kitty W. M. Bloemenkamp, Hubertina C. J. Scheepers, Yves Jaquemyn, Erik van Beek, Hans J. J. Duvekot, Maureen T. M. Franssen, Bas N. Bijvank, Joke H. Kok, Arie Franx, Ben Willem J. Mol, Martijn A. Oudijk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number93
JournalBMC Pregnancy and Childbirth
Volume14
DOIs
Publication statusPublished - 3 Mar 2014

Keywords

  • Preterm birth
  • Tocolytics
  • Nifedipine
  • Atosiban
  • Outcome
  • Drug safety

Cite this

van Vliet, E. O. G., Schuit, E., Heida, K. Y., Opmeer, B. C., Kok, M., Gyselaers, W., Porath, M. M., Woiski, M., Bax, C. J., Bloemenkamp, K. W. M., Scheepers, H. C. J., Jaquemyn, Y., van Beek, E., Duvekot, H. J. J., Franssen, M. T. M., Bijvank, B. N., Kok, J. H., Franx, A., Mol, B. W. J., & Oudijk, M. A. (2014). Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial). BMC Pregnancy and Childbirth, 14, [93]. https://doi.org/10.1186/1471-2393-14-93